CIK 0001787297 · Non-accelerated filer<br>Smaller reporting company
Passage BIO, Inc.
Sign in to watch- Ticker
- PASG
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 822729751
- Phone
- 2678660312
- Business address
- ONE COMMERCE SQUARE, 2005 MARKET STREET, 39TH FLOOR, PHILADELPHIA, PA, 19103
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-07-22 | Lynx1 Capital Management LP 10% owner | Purchase | +13,123 | $5.44 | $71K | 475,971 |
| 2025-06-26 | ORBIMED ADVISORS LLC 10% owner | Sale | −213,257 | $0.33 | $70K | 6,066,343 |
| 2025-06-25 | ORBIMED ADVISORS LLC 10% owner | Sale | −138,800 | $0.33 | $46K | 6,279,600 |
| 2025-06-24 | ORBIMED ADVISORS LLC 10% owner | Sale | −231,600 | $0.35 | $81K | 6,418,400 |
| 2025-05-28 | Kapadia Sandip Director | Grant or award · Director Stock Option (right to buy) | +201,857 | 201,857 | ||
| 2025-05-28 | GOWEN MAXINE Director | Grant or award · Director Stock Option (right to buy) | +201,857 | 201,857 | ||
| 2025-05-28 | Countouriotis Athena Director | Grant or award · Director Stock Option (right to buy) | +201,857 | 201,857 | ||
| 2025-05-28 | Porter Derrell Director | Grant or award · Director Stock Option (right to buy) | +201,857 | 201,857 | ||
| 2025-05-28 | Islam Saqib Director | Grant or award · Director Stock Option (right to buy) | +201,857 | 201,857 | ||
| 2025-05-28 | Sondhi Dolan Director | Grant or award · Director Stock Option (right to buy) | +201,857 | 201,857 | ||
| 2025-05-28 | Kassberg Thomas Richard Director | Grant or award · Director Stock Option (right to buy) | +143,789 | 143,789 | ||
| 2025-04-24 | ORBIMED ADVISORS LLC 10% owner | Sale | −68,195 | $0.32 | $22K | 6,650,000 |
| 2025-04-23 | ORBIMED ADVISORS LLC 10% owner | Sale | −89,328 | $0.34 | $30K | 6,718,195 |
| 2025-04-22 | ORBIMED ADVISORS LLC 10% owner | Sale | −78,049 | $0.34 | $27K | 6,807,523 |
| 2025-04-17 | ORBIMED ADVISORS LLC 10% owner | Sale | −77,090 | $0.33 | $25K | 6,885,572 |
| 2025-04-16 | ORBIMED ADVISORS LLC 10% owner | Sale | −61,638 | $0.33 | $20K | 6,962,662 |
| 2025-04-15 | ORBIMED ADVISORS LLC 10% owner | Sale | −10,326 | $0.38 | $4K | 7,024,300 |
| 2025-03-15 | Borthwick Kathleen CFO | Grant or award · Employee Stock Option (right to buy) | +278,386 | 278,386 | ||
| 2025-03-15 | Chou William PRESIDENT AND CEO | Grant or award · Employee Stock Option (right to buy) | +779,533 | 779,533 | ||
| 2025-03-15 | Cale Edgar B. GC & CORPORATE SECRETARY | Grant or award · Employee Stock Option (right to buy) | +278,386 | 278,386 |
Page 2 of 8 · 152 trades